Acadian Asset Management LLC Novo Nordisk A S Transaction History

Acadian Asset Management LLC

$28.7 Billion
Q1 2024

A detailed history of Acadian Asset Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,244,128 shares of NVO stock, worth $168 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

1,244,128

Previous 88,815 1300.81%

Holding current value

$168 Million

Previous $9.18 Million 1640.25%

% of portfolio

0.56%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $118 Million - $157 Million	1,155,313 Added 1300.81%	1,244,128 $160 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $7.28 Million - $8.75 Million	82,963 Added 1417.69%	88,815 $9.18 Million
Q3 2023 Nov 13, 2023	SELL	$90.94 - $199.54 $258,451 - $567,092	-2,842 Reduced 32.69%	5,852 $531,000
Q2 2023 Aug 07, 2023	BUY	$155.98 - $172.65 $647,161 - $716,324	4,149 Added 91.29%	8,694 $1.41 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $562,842 - $676,822	-4,253 Reduced 48.34%	4,545 $723,000

Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $108,190 - $142,773	-1,055 Reduced 10.71%	8,798 $1.19 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $164,693 - $199,083	-1,769 Reduced 15.22%	9,853 $1.09 Million
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $15,532 - $18,966	-162 Reduced 1.37%	11,622 $1.3 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $994,805 - $1.26 Million	11,784 New	11,784 $1.13 Million
Q1 2021 May 11, 2021	SELL	$67.06 - $75.82 $1.18 Million - $1.33 Million	-17,559 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$63.89 - $73.8 $575 - $664	-9 Reduced 0.05%	17,559 $1.23 Million
Q2 2020 Aug 12, 2020	BUY	$58.54 - $67.94 $78,853 - $91,515	1,347 Added 8.3%	17,568 $1.15 Million
Q1 2020 May 11, 2020	BUY	$49.46 - $64.78 $802,290 - $1.05 Million	16,221 New	16,221 $977,000
Q4 2019 Feb 06, 2020	SELL	$49.86 - $58.26 $46,519 - $54,356	-933 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$47.54 - $53.43 $44,354 - $49,850	933 New	933 $48,000
Q4 2017 Jan 18, 2018	SELL	$47.53 - $53.73 $60,505 - $68,398	-1,273 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$41.15 - $49.22 $52,383 - $62,657	1,273	1,273 $61,000

Others Institutions Holding NVO

# of Institutions

1,851

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $305B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Novo Nordisk A S Transaction History